82_FR_16468 82 FR 16405 - National Institute on Aging; Notice of Closed Meetings

82 FR 16405 - National Institute on Aging; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 63 (April 4, 2017)

Page Range16405-16405
FR Document2017-06553

Federal Register, Volume 82 Issue 63 (Tuesday, April 4, 2017)
[Federal Register Volume 82, Number 63 (Tuesday, April 4, 2017)]
[Notices]
[Page 16405]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-06553]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Aging; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Aging Initial Review 
Group, Biological Aging Review Committee.
    Date: May 30-31, 2017.
    Time: 2:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Torrance Marriott Redondo Beach, 3635 Fashion Way, 
Torrance, CA 90503.
    Contact Person: Bita Nakhai, Ph.D., Scientific Review Branch, 
National Institute on Aging, Gateway Bldg., 2C212, 7201 Wisconsin 
Avenue, Bethesda, MD 20814, 301-402-7701, [email protected].

    Name of Committee: National Institute on Aging Initial Review 
Group, Neuroscience of Aging Review Committee,
    Date: June 1-2, 2017.
    Time: 2:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Torrance Marriott Redondo Beach, 3635 Fashion Way, 
Torrance, CA 90503.
    Contact Person: Jeannette L. Johnson, Ph.D., Deputy Review 
Branch Chief, National Institutes of Health, National Institute on 
Aging, Gateway Building, Bethesda, MD 20892, 301-402-7705, 
[email protected].

    Name of Committee: National Institute on Aging Initial Review 
Group, Clinical Aging Review Committee.
    Date: June 1-2, 2017.
    Time: 2:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Torrance Marriott Redondo Beach, 3635 Fashion Way, 
Torrance, CA 90503.
    Contact Person: Alicja L. Markowska, Ph.D., Dsc., National 
Institute on Aging, National Institutes of Health, Gateway Building 
2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301-496-9666, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging 
Research, National Institutes of Health, HHS)


    Dated: March 29, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-06553 Filed 4-3-17; 8:45 am]
 BILLING CODE 4140-01-P



                                                                                    Federal Register / Vol. 82, No. 63 / Tuesday, April 4, 2017 / Notices                                  16405

                                                    discussion, and evaluation of                             Name of Committee: National Institute on          Only written comments and/or
                                                                                                                                                                  DATES:
                                                    applications received in response to                    Aging Initial Review Group, Neuroscience of applications for a license which are
                                                    ‘‘Community Characteristics Associated                  Aging Review Committee,                     received by the NHLBI Office of
                                                                                                              Date: June 1–2, 2017.
                                                    with Geographic Disparities in Diabetes                   Time: 2:00 p.m. to 2:00 p.m.
                                                                                                                                                        Technology Transfer and Development
                                                    and Cardiometabolic Health’’, DP17–                       Agenda: To review and evaluate grant      on or before April 19, 2017 will be
                                                    001.                                                    applications.                               considered.
                                                       Contact Person for More Information:                   Place: Torrance Marriott Redondo Beach,   ADDRESSES: Requests for copies of the
                                                    Jaya Raman Ph.D., Scientific Review                     3635 Fashion Way, Torrance, CA 90503.       patent application, inquiries, and
                                                                                                              Contact Person: Jeannette L. Johnson,
                                                    Officer, CDC, 4770 Buford Highway,                                                                  comments relating to the contemplated
                                                                                                            Ph.D., Deputy Review Branch Chief, National
                                                    Mailstop F80, Atlanta, Georgia 30341,                   Institutes of Health, National Institute on exclusive license should be directed to:
                                                    Telephone: (770) 488–6511, kva5@                        Aging, Gateway Building, Bethesda, MD       Cristina Thalhammer-Reyero, Ph.D.,
                                                    cdc.gov.                                                20892, 301–402–7705, johnsonj9@             MBA, Senior Licensing and Patenting
                                                       The Director, Management Analysis                    nia.nih.gov.                                Manager, NHLBI Office of Technology
                                                    and Services Office, has been delegated                   Name of Committee: National Institute on  Transfer and Development, 31 Center
                                                    the authority to sign Federal Register                  Aging Initial Review Group, Clinical Aging  Drive Room 4A29, MSC2479, Bethesda,
                                                                                                            Review Committee.                           MD 20892–2479; Telephone: +1–301–
                                                    notices pertaining to announcements of                    Date: June 1–2, 2017.
                                                    meetings and other committee                                                                        435–4507; Fax: +1–301–594–3080;
                                                                                                              Time: 2:00 p.m. to 2:00 p.m.              Email: thalhamc@mail.nih.gov.
                                                    management activities, for both the                       Agenda: To review and evaluate grant
                                                    Centers for Disease Control and                         applications.                               SUPPLEMENTARY INFORMATION: The
                                                    Prevention and the Agency for Toxic                       Place: Torrance Marriott Redondo Beach,   following represents the intellectual
                                                    Substances and Disease Registry.                        3635 Fashion Way, Torrance, CA 90503.       property to be licensed under the
                                                                                                              Contact Person: Alicja L. Markowska,      prospective agreement:
                                                    Elaine L. Baker,                                        Ph.D., Dsc., National Institute on Aging,      U.S. Provisional Patent Application
                                                    Director, Management Analysis and Services              National Institutes of Health, Gateway      Serial No. 61/045,213, filed 04/15/2008;
                                                    Office, Centers for Disease Control and                 Building 2C212, 7201 Wisconsin Avenue,      PCT Application No. PCT/US2009/
                                                    Prevention.                                             Bethesda, MD 20892, 301–496–9666,
                                                                                                                                                        040560, filed 04/14/2009; U.S. Patent
                                                    [FR Doc. 2017–06536 Filed 4–3–17; 8:45 am]              markowsa@nia.nih.gov.
                                                                                                                                                        Application Serial No.12/937,974,
                                                                                                            (Catalogue of Federal Domestic Assistance
                                                    BILLING CODE 4163–18–P
                                                                                                            Program Nos. 93.866, Aging Research,
                                                                                                                                                        issued as 8,936,787 on 01/20/2015;
                                                                                                            National Institutes of Health, HHS)         Titled ‘‘Peptides Promoting Lipid
                                                                                                                                                        Efflux’’ (NIH Reference No. E–138–
                                                    DEPARTMENT OF HEALTH AND                                   Dated: March 29, 2017.                   2008/0).
                                                    HUMAN SERVICES                                          Melanie J. Pantoja,                            With respect to persons who have an
                                                                                                            Program Analyst, Office of Federal Advisory obligation to assign their right, title and
                                                    National Institutes of Health                           Committee Policy.                           interest to the Government of the United
                                                    National Institute on Aging; Notice of                  [FR Doc. 2017–06553 Filed 4–3–17; 8:45 am]  States of America, the patent rights in
                                                    Closed Meetings                                         BILLING CODE 4140–01–P                      these inventions have been assigned to
                                                                                                                                                        the Government of the United States of
                                                      Pursuant to section 10(d) of the                                                                  America.
                                                    Federal Advisory Committee Act, as                      DEPARTMENT OF HEALTH AND                       The prospective exclusive license
                                                    amended (5 U.S.C. App.), notice is                      HUMAN SERVICES                              territory may be worldwide and the
                                                    hereby given of the following meetings.                                                             field of use may be limited to:
                                                                                                            National Institutes of Health               ‘‘Treatment of Hypertriglyceridemia,
                                                      The meetings will be closed to the                                                                with or without concomitant metabolic
                                                    public in accordance with the                           Prospective Grant of Exclusive Patent       syndrome’’.
                                                    provisions set forth in sections                        License: Development and                       The invention pertains to
                                                    552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,              Commercialization of Peptides               compositions and methods of use of
                                                    as amended. The grant applications and                  Promoting Lipid Efflux for the              ApoC–II mimetic peptides with
                                                    the discussions could disclose                          Treatment of Hypertriglyceridemia,          multiple amphipathic alpha helical
                                                    confidential trade secrets or commercial                With or Without Concomitant                 domains that have the dual ability to
                                                    property such as patentable material,                   Metabolic Syndrome                          promote lipid efflux from cells and
                                                    and personal information concerning                     AGENCY: National Institutes of Health,      stimulate lipoprotein lipase activity,
                                                    individuals associated with the grant                   HHS.                                        without inducing toxicity. This notice is
                                                    applications, the disclosure of which                                                               made in accordance with 35 U.S.C. 209
                                                                                                            ACTION: Notice.
                                                    would constitute a clearly unwarranted                                                              and 37 CFR part 404. The prospective
                                                    invasion of personal privacy.                           SUMMARY: The National Heart, Lung, and Exclusive Patent License will be royalty
                                                      Name of Committee: National Institute on              Blood Institute (NHLBI), an institute of    bearing and may be granted unless
                                                    Aging Initial Review Group, Biological Aging            the National Institutes of Health; an       within fifteen (15) days from the date of
                                                    Review Committee.                                       agency within the Department of Health this published notice, the NHLBI Office
                                                      Date: May 30–31, 2017.                                and Human Services, is contemplating        of Technology Transfer and
                                                      Time: 2:00 p.m. to 2:00 p.m.                          the grant of an exclusive patent license    Development receives written evidence
asabaliauskas on DSK3SPTVN1PROD with NOTICES




                                                      Agenda: To review and evaluate grant                  to commercialize the invention(s)           and argument that establishes that the
                                                    applications.                                           embodied in the intellectual property       grant of the license would not be
                                                      Place: Torrance Marriott Redondo Beach,
                                                    3635 Fashion Way, Torrance, CA 90503.
                                                                                                            estate stated in the Summary                consistent with the requirements of 35
                                                      Contact Person: Bita Nakhai, Ph.D.,                   Information section of this notice to       U.S.C. 209 and 37 CFR part 404.
                                                    Scientific Review Branch, National Institute            Corvidia Therapeutics Inc. (Corvidia)          Complete applications for a license in
                                                    on Aging, Gateway Bldg., 2C212, 7201                    located in Waltham, MA and                  the prospective field of use that are
                                                    Wisconsin Avenue, Bethesda, MD 20814,                   incorporated under the laws of              timely filed in response to this notice
                                                    301–402–7701, nakhaib@nia.nih.gov.                      Delaware.                                   will be treated as objections to the grant


                                               VerDate Sep<11>2014   16:21 Apr 03, 2017   Jkt 241001   PO 00000   Frm 00072   Fmt 4703   Sfmt 4703   E:\FR\FM\04APN1.SGM   04APN1



Document Created: 2017-04-03 23:54:04
Document Modified: 2017-04-03 23:54:04
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMay 30-31, 2017.
FR Citation82 FR 16405 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR